ME - Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
2024-03-24 03:23:00 ET
If you're an individual investor who wants to invest like a billionaire fund manager, I've got good news. Following billionaires is relatively easy because the U.S. Securities and Exchange Commission makes anyone who manages over $100 million in assets report their trading activity every quarter.
In the last three months of 2023, several prominent billionaires bought shares of 23andMe (NASDAQ: ME) even though the stock has been plunged from its previous peak.
Before plowing any of your hard-earned money into the genetic testing stock, it's important to remember that even the most successful investors can be wrong from time to time.
For further details see:
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?